Comparison of estradiol and progesterone priming/antagonist/letrozole and microdose flare-up protocols for poor responders undergoing intracytoplasmic sperm injection

Gynecological Endocrinology

Volumn 30, Issue 9, 2014, Pages 653-656

  Yucel, Oguz ^a   Ekin, Murat ^b   Cengiz, Hüseyin ^b   Zebitay, Ali Galip ^a   Yalcinkaya, Sener ^a   Karahuseyinoglu, Sercin ^a  

^a Suleymaniye Maternity and Women s Disease Education and Research Hospital   (Turkey)

^b BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Assisted reproductive technology; Estrogens; Infertility; Ovulation induction

Indexed keywords

ESTRADIOL; GONADOTROPIN; LETROZOLE; PROGESTERONE; GONADORELIN; NITRILE; TRIAZOLE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BODY MASS; DRUG MICRODOSE; FEMALE; FEMALE INFERTILITY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MATERNAL AGE; OVARIAN RESERVE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; TRANSDERMAL PATCH; TRANSVAGINAL ECHOGRAPHY; AGONISTS; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; PREGNANCY; PROCEDURES; RETROSPECTIVE STUDY;

ADULT; ESTRADIOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; NITRILES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROGESTERONE; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TRIAZOLES;

EID: 84906254463     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.920002     Document Type: Article

References (27)

1. Surrey E, Schoolcraft W. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive technologies. Fertil Steril 2000; 73: 667-76.
2. Bancsi LF, Broekmans FJ, Eijkemans MJ, et al. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002; 77: 328-36.
3. Jenkins JM, Davies DW, Devonport H, et al. Comparison of ''poor'' responders with ''good'' responders using a standard buserelin/ human menopausal gonadotropin regime for in-vitro fertilization. Hum Reprod 1991; 6: 918-21.
4. Pellicer A, Lightman A, Diamond MP, et al. Outcome of in vitro fertilization in women with low response to ovarian stimulation. Fertil Steril 1987; 47: 812-15.
5. Detti L, Williams DB, Robins JC, et al. A comparison of three down regulation approaches for poor responders undergoing in vitro fertilization. Fertil Steril 2005; 84: 1401-5.
6. Schoolcraft W, Schlenker T, Gee M, et al. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle stimulating hormone flare, growth hormone protocol. Fertil Steril 1997; 67: 93-7.
7. Schmidt DW, Bremner T, Orris JJ, et al. A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril 2005; 83: 1568-71.
8. Scott R, Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonists during ovulation induction for in vitro fertilization. Fertil Steril 1994; 61: 880-5.
9. Surrey E, Bower J, Hill D, et al. Clinical and endocrine effects of a microdose GnRH agonist flare regime administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998; 69: 419-24.
10. Winer EP, Hudis C, Burstein HJ, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol 2002; 20: 3317-27.
11. Weil SJ, Vendola K, Zhou J, et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 1998; 83: 2479-85.
12. Mitwally M, Casper R. Aromatase inhibition improves ovarian response to follicle stimulation hormone in poor responders. Fertil Steril 2002; 77: 776-80.
13. Goswami SK, Das T, Chattopadhyay R, et al. A randomized singleblind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod 2004; 19: 2031-5.
14. Schoolcraft WB, Surrey ES, Minjarez DA, et al. Management of poor responders: can outcomes be improved with a novel gonadotropin- releasing hormone antagonist/letrozole protocol? Fertil Steril 2008; 89: 151-6.
15. Oktay K, Cil A, Oktem O, Bang H. Continuous combined letrozole- FSH stimulation requires less FSH with similar outcomes compared to standard ovarian stimulation regimens for IVF. Fertil Steril 2005; 84: S94.
16. Fanchin R, Salomon L, Castelo-Branco A, et al. Luteal estradiol pretreatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod 2003; 18: 2698-703.
17. Ferraretti AP, La Marca A, Fauser BCJM, et al.; On behalf of the ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reprod 2011; 26: 1616-24.
18. Akman MA, Erden HF, Tosun SB, et al. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001; 16: 868-70.
19. Schmidt DW, Bremner T, Orris JJ, et al. A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril 2005; 83: 1568-71.
20. Casper RF, Mitwally MF. Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 2006; 91: 760-71.
21. Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001; 75: 305-9.
22. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and folliclestimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999; 84: 2951-6.
23. Garcia-Velasco JA, Moreno L, Pacheco A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 2005; 84: 82-7.
24. Kapoor M, Hurwitz J, Polotsky A, et al. Letrozole in combination with gonadotropins decreases cancellation rates and improves ongoing pregnancy rates per transfer in poor responders. Fertil Steril 2007; 88: S100.
25. Yarali H, Esinler I, Polat M, et al. Antagonist/letrozole protocol in poor ovarian responders for intracytoplasmic sperm injection: a comparative study with the microdose flare-up protocol. Fertil Steril 2009; 92: 231-5.
26. Shastri S, Barbieri E, Kligman I, et al. Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide Fertil Steril 2011; 95: 592-5.
27. Hill MJ, Grant D, McWilliams E, et al. A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates. Fertil Steril 2009; 91: 739-43.